Purchase Order 75N95023P00645
Award Date
8/28/23
Potential Completion Date
8/27/24
Potential Value
$89K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Sanaria Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $303,590.36 firm fixed price purchase order contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Sanaria Inc., a for-profit organization and veteran-owned business that manufactures goods. The contract is for a 24-month malaria culture service to provide asexual malaria blood stage cultures and enriched late-stage gametocyte cultures to support malaria drug development efforts. This award is not associated...
This is a $3,397,349.60 fixed-price level of effort contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery to Sanaria Inc., a veteran-owned biotechnology company, for a Phase III clinical trial of an investigational malaria vaccine. The contract is for the production and delivery of Plasmodium falciparum sporozoites, the parasite that causes malaria, to support the clinical trial. Sanaria Inc. has previously provided services to the National Institutes of Health and...
This is a $2,399,997.00 federal contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Sanaria Inc., a for-profit, veteran-owned biotechnology company that manufactures goods. The contract is for research and development services, including providing asexual malaria blood culture service and conducting phase III clinical trials for an investigational malaria vaccine involving Plasmodium falciparum sporozoites. Sanaria Inc. has also received grants from the National...
This federal contract award was issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Sanaria Inc., a biotechnology company focused on the development of malaria vaccines. The $149,931.25 firm-fixed-price purchase order is for the delivery of purified, vialed, and cryopreserved products, with a period of performance ending on February 29, 2016. Sanaria Inc. has previously received federal grants and contracts related to the research, development, and...
This is a $5,699,486.00 federal contract award from the Bureau of Medicine and Surgery, a defense agency, to Sanaria Inc., a for-profit, veteran-owned business and manufacturer. The contract is for research and development services, with a performance period ending on October 31, 2018. Sanaria Inc. has provided services such as asexual malaria blood culture, clinical trial services for an investigational malaria vaccine, and research and development of P. falciparum sporozoite vaccines. This...
This is a $999,997.00 firm fixed-price SBIR Phase II R&D contract awarded by the Defense Health Agency (DHA) to Sanaria Inc., a small business veteran-owned manufacturer. The contract is for the "Delivery System for Cryopreserved Eukaryotic Cell Vaccines," supporting Sanaria's work on an investigational malaria vaccine using Plasmodium falciparum sporozoites. Sanaria has previously received federal funding for malaria vaccine research, development, and manufacturing from agencies...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $298,596 definitive contract to Sanaria Inc. of Potomac, MD for Research Type Small Business Innovation Research Program Phase I Action. The contract is a firm fixed price award with a period of performance from August 30, 2022 through April 1, 2024. The place of performance is Potomac, MD and the contract has a total small business set aside...
This is a federal research and development contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Sanaria Inc., a biotechnology company, for the development of a multi-strain malaria vaccine. The contract has a total potential value of $2,799,216.00 and is a definitive contract with a cost-no-fee pricing type. The contract does not have a set-aside designation and is set to be completed by July 18, 2019. Sanaria Inc. has previously provided services to support malaria...
This is a delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Sri International, a non-profit research institute. The contract is for an oral therapy for the prevention and treatment of malaria, with a period of performance from September 16, 2020 to March 15, 2021. The contract has a potential value of $439,121.00 and is a Cost Plus Fixed Fee type. The contract is not...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $216,444 Small Business Innovation Research (SBIR) Phase I contract to Crosslife Technologies Inc., a self-certified small disadvantaged business, to conduct research and development on diagnostics to enable the detection and elimination of malaria and neglected tropical diseases. The contract was awarded under the NIH/CDC SBIR Contract Solicitation PHS...